Clinical Trials Logo
NCT number NCT03494660
Study type Observational
Source Zimmer Biomet
Contact Lynsey Boyle, BS
Phone 484-467-7047
Email lynsey.boyle@zimmerbiomet.com
Status Recruiting
Phase
Start date March 27, 2018
Completion date March 2025

Clinical Trial Summary

Post-market clinical outcomes study to collect data on the short- and long-term outcomes for subjects who are undergoing or have undergone the Subchondroplasty® (SCP®) Procedure in the hip in a standard clinical setting. Outcomes to be assessed include medication usage, pain, function, activity levels and patient satisfaction.


Clinical Trial Description

This study is designed as a post-market, single arm, non-randomized multi-center investigation.

Male and female subjects, at least 18 years of age, with at least one subchondral bone defect in the form of a cyst and/or bone marrow lesion (BML), insufficiency fracture or bone defect associated with early stage avascular osteonecrosis (AVN) in the femoral head, femoral neck and/or acetabulum who are suitable candidates for use of AccuFill during the Subchondroplasty Procedure are eligible for enrollment in this study.

A maximum of 15 study sites, in the United States of America, will enroll a target of 100 subjects.

Each Investigator must obtain IRB approval, or favorable opinion by an EC, prior to consent of the first subject; no study-related procedures can occur without the approval and oversight of a registered IRB or EC. If the study site does not have an IRB of record, a central IRB may be utilized upon approval by Zimmer Biomet.

Demographics, medical history, hip history and use of pain medication and therapy will be recorded at the time of subject consent. Additionally, patient reported outcomes measures will be obtained pre-operatively. Operative details including the SCP Procedure, concomitant surgical procedures and intraoperative safety events will be recorded at the time of surgery. Prospective subjects will be considered enrolled in this study once their Subchondroplasty Procedure has been performed.

Subjects will complete only the Numeric Pain Scale at 2 weeks post-operatively. Thereafter, subjects will complete self-reported outcomes measures post-operatively at 6 weeks, 12 weeks, 6 months, 1 year and 2 years. These measures include information on pain medication and therapy, pain levels, function, activity and subject satisfaction. A member of the study staff will contact subjects post-operatively at 3 years, 4 years and 5 years by telephone to verify completion of the Numeric Pain Scale and a Subject Global Satisfaction Survey. Screening for adverse events and conversion will occur throughout the study.

Subjects will complete the study at 5 years or will be withdrawn if they undergo conversion of the Subchondroplasty site. For the purposes of this protocol, a conversion will be defined as total hip arthroplasty or any procedure involving removal of the AccuFill material on the index hip.


Study Design


Related Conditions & MeSH terms


See also
  Status Clinical Trial Phase
Recruiting NCT01623843 - Femoroacetabular Impingement RandomiSed Controlled Trial N/A
Withdrawn NCT02674113 - Regional Anesthesia in Hip Arthroscopy N/A
Withdrawn NCT02260726 - Evaluation of Ultrasound for Detecting Hip Impingement N/A
Recruiting NCT03278353 - Fulfillment of Expectations for Patients With FAI Syndrome N/A
Recruiting NCT01621360 - Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement N/A
Withdrawn NCT02706756 - Conservative Intervention of Femoroacetabular Impingement Syndrome N/A
Completed NCT01993615 - A Physical Therapy Program Versus Surgery for Femoroacetabular Impingement: Randomized Clinical Trial N/A
Completed NCT01814124 - Conservative Management of Femoroacetabular Impingement N/A
Completed NCT02702661 - PRCT of FICB vs LAI for Hip Arthroscopy N/A
Not yet recruiting NCT03506620 - The Role of Nerve Blocks in Hip Arthroscopy Phase 4
Completed NCT01799200 - Hip Pathomorphology in Collegiate Athletes and Controls N/A
Enrolling by invitation NCT02183896 - Efficacy of PRP (Platelet Rich Plasma) Following Arthroscopic Microfracture of Chondral Lesions of the Hip N/A
Recruiting NCT01893034 - Trial for Femoroacetabular Impingement Treatment N/A
Completed NCT01578694 - Characterization of Proteoglycan Depletion in Femoroacetabular Impingement With T1ρ Magnetic Resonance Imaging (MRI) N/A
Recruiting NCT02664337 - Conjoint Analysis of Patient Preferences in Joint Interventions N/A
Completed NCT02880085 - Marker for FAI Diagnosis N/A
Active, not recruiting NCT03077022 - Femoroacetabular Impingement (FAI): The Effectiveness of Physical Therapy
Recruiting NCT02408276 - Longitudinal Evaluation of Hip Cartilage Degeneration: FAI
Active, not recruiting NCT01546493 - Hip Impingement - Understanding Cartilage Damage N/A
Recruiting NCT02920177 - Platelet-rich Plasma Versus Corticosteroid Injection for the Treatment of Femoroacetabular Impingement Phase 4